Logo der Universitätsmedizin Göttingen
Klinik für Urologie
Forschung > Publikationen

Publikationen der Klinik für Urologie

Publikationen 2024

1.    Bachanek S, Wuerzberg P, Biggemann L, Janssen TY, Nietert M, Lotz J, Zeuschner P, Maßmann A, Uhlig A, Uhlig J (2024) Renal tumor segmentation, visualization, and segmentation confidence using ensembles of neural networks in patients undergoing surgical resection. EUR RADIOL Online ahead of print: Online ahead of print, doi: 10.1007/s00330-024-11026-6


2.    Dahm P, Ergun O, Uhlig A, Bellut L, Risk MC, Lyon JA, Kunath F (2024) Cytoreductive nephrectomy in metastatic renal cell carcinoma. COCHRANE DB SYST REV 6(6): CD013773, doi: 10.1002/14651858.CD013773.pub2


3.    Hirtsiefer C, Nestler T, Eckrich J, Beverungen H, Siech C, Aksoy C, Leitsmann M, Baunacke M, Uhlig A (2024) Capabilities of ChatGPT-3.5 as a Urological Triage System. EUR UROL OPEN SCI 70: 148-153, doi: 10.1016/j.euros.2024.10.015


4.    Hosni S, Kilian V, Klümper N, Gabbia D, Sieckmann K, Corvino D, Winkler A, Saponaro M, Wörsdörfer K, Schmidt D, Hahn O, Zanotto I, Bertlich M, Toma M, Bald T, Eckstein M, Hölzel M, Geyer M, Ritter M, Wachten D, De Martin S, Alajati A (2024) Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in Urothelial Carcinoma. CANCER RES 84(5): 725-740, doi: 10.1158/0008-5472.CAN-23-1398


5.    Klümper N, Tran NK, Zschäbitz S, Hahn O, Büttner T, Roghmann F, Bolenz C, Zengerling F, Schwab C, Nagy D, Toma M, Kristiansen G, Heers H, Ivanyi P, Niegisch G, Grunewald CM, Darr C, Farid A, Schlack K, Abbas M, Aydogdu C, Casuscelli J, Mokry T, Mayr M, Niedersüß-Beke D, Rausch S, Dietrich D, Saal J, Ellinger J, Ritter M, Alajati A, Kuppe C, Meeks J, Vera Badillo FE, Nakauma-González JA, Boormans J, Junker K, Hartmann A, Grünwald V, Hölzel M, Eckstein M (2024) NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer. J CLIN ONCOL 42(20): 2446-2455, doi: 10.1200/JCO.23.01983


6.    Leitsmann C, Kahlmeier L, Lampe PO, Groeben C, Baunacke M, Huber J, Trojan L, Uhlig J, Leitsmann M, Uhlig A, Arbeitsgruppe „Versorgungsforschung & Digital health“ der GeSRU Academics, Arbeitskreis „Versorgungsforschung Qualität und Ökonomie“ der DGU e. V. (2024) [Comparison of hospital rating websites among each other and with data from hospital quality reports and quality assurance based on routine data]. UROLOGIE 63(5): 474-481, doi: 10.1007/s00120-023-02263-6


7.    Mohr MN, Ploeger HM, Leitsmann M, Leitsmann C, Gayer FA, Trojan L, Reichert M (2024) Precise Prediction of Long-Term Urinary Incontinence after Robot-Assisted Laparoscopic Radical Prostatectomy by Readily Accessible "Everyday" Diagnostics during Post-Surgical Hospitalization. CLINICS PRACT 14(3): 661-671, doi: 10.3390/clinpract14030053


8.    Popeneciu IV, Mohr MN, Strauß A, Leitsmann C, Trojan L, Reichert M (2024) Personalized Treatment Strategy in "Low-Risk Prostate Cancer Active Surveillance Candidates" Using Irreversible Electroporation: Prospective Evaluation of Feasibility, Morbidity, Functional and Oncological Outcomes. WORLD J MENS HEALTH 42(4): 821-829, doi: 10.5534/wjmh.230097


9.    Reichert M, Strauß A, Voß JW, von Knobloch HC, Neuenhofer HM, Uhlig A, Trojan L, Mohr MN (2024) Surgical approach affecting long-term urinary continence status after robot-assisted laparoscopic prostatectomy prospectively evaluated using self-reported functional status (Expanded Prostate Cancer Index Composite, EPIC-26). CURR UROL 18(1): 61-65, doi: 10.1097/CU9.0000000000000190


10.    Schild-Suhren S, Yilmaz E, Biggemann L, Seif A, Torsello GF, Uhlig A, Ghadimi M, Bösch F (2024) [Management of Injuries to the Parenchymal Abdominal Organs]. ZBL CHIR 149(4): 359-367, doi: 10.1055/a-2301-7951


11.    Schneidewind L, Kiss B, Kranz J, Zengerling F, Borkowetz A, Graf S, Graser A, Uhlig A (2024) Gender-Specific Differences in Recurrence and Progression following Bacillus Calmette-Guérin Instillation for Non-Muscle-Invasive Bladder Cancer. UROL INT Online ahead of print: 1-13, doi: 10.1159/000542473


12.    Uhlig A (2024) [Androgen Receptor Signaling Inhibitors and Cardiovascular Events in Advanced Prostate Cancer: A Systematic Review and Meta-Analysis]. UROLOGIE 63(12): 1276-1280, doi: 10.1007/s00120-024-02464-7


13.    Uhlig A, Bergmann L, Bögemann M, Fischer T, Goebell PJ, Leitsmann M, Reichert M, Rink M, Schlack K, Trojan L, Uhlig J, Woike M, Strauß A (2024) Sunitinib for Metastatic Renal Cell Carcinoma: Real-World Data from the STAR-TOR Registry and Detailed Literature Review. UROL INT 108(3): 198-210, doi: 10.1159/000536563


14.    Uhlig A, Uhlig J, Leha A, Biggemann L, Bachanek S, Stöckle M, Reichert M, Lotz J, Zeuschner P, Maßmann A (2024) Radiomics and machine learning for renal tumor subtype assessment using multiphase computed tomography in a multicenter setting. EUR RADIOL 34(10): 6254-6263, doi: 10.1007/s00330-024-10731-6


15.    Uhlig A, Uhlig J, Shuch B, Kim HS (2024) Stage IA papillary and chromophobe renal cell carcinoma: effectiveness of cryoablation and partial nephrectomy. INSIGHTS IMAGING 15(1): 171, doi: 10.1186/s13244-024-01749-x


16.    Uhlig J, Uhlig A, Deshpande H, Ströbel P, Trojan L, Lotz J, Hurwitz M, Hafez O, Humphrey P, Grünwald V, Kim HS (2024) Epidemiology, treatment and outcomes of primary renal sarcomas in adult patients. SCI REP-UK 14(1): 10038, doi: 10.1038/s41598-024-60174-8


17.    Weiten R, Niemann M, Below E, Friker LL, Ralser DJ, Toma M, Kristiansen G, Hahn O, Zechel S, Grünwald V, Bald T, Siewert J, Pietsch T, Ritter M, Hölzel M, Eckstein M, Alajati A, Krausewitz P, Klümper N (2024) Preclinical evidence for the use of anti-Trop-2 antibody-drug conjugate Sacituzumab govitecan in cerebral metastasized castration-resistant prostate cancer. CANCER MED-US 13(12): e7320, doi: 10.1002/cam4.7320
 

Publikationen 2023

1.    Al-Bourini O, Seif Amir Hosseini A, Biggemann L, Uhlig A, Balz J, Haas L, Voit D, Lotz J, Frahm J, Uhlig J (2023) T1 mapping of the prostate using Single-Shot T1FLASH and MOLLI MRI Techniques: Comparison of artifact burden and image quality. EUR J RADIOL 162: 110783, doi: 10.1016/j.ejrad.2023.110783


2.    Al-Bourini O, Seif Amir Hosseini A, Giganti F, Balz J, Heitz LG, Voit D, Lotz J, Trojan L, Frahm J, Uhlig A, Uhlig J (2023) T1 Mapping of the Prostate Using Single-Shot T1FLASH: A Clinical Feasibility Study to Optimize Prostate Cancer Assessment. INVEST RADIOL 58(6): 380-387, doi: 10.1097/RLI.0000000000000945


3.    Baier E, Korsten P, Strauß A, Thoms KM, Overbeck T, Ströbel P, Tampe B (2023) Study protocol: a prospective single-center study for non-invasive biomonitoring of renal complications in cancer patients treated with immune checkpoint inhibitors. FRONT IMMUNOL 14: 1140677, doi: 10.3389/fimmu.2023.1140677


4.    Baierl MA, Strauß A, Uhlig A, Hahn O, Reichert M, Schneider TR, Lüdecke J, Mohr MN, Voß JW, von Knobloch HC, Trojan L, Leitsmann C, Leitsmann M (2023) [Use of men's support underwear after elective scrotal surgery-a prospective, randomized assessment of postoperative complication rates and health-related quality of life: A prospective, randomized assessment of postoperative complication rates and health-related quality of life]. Urologie 62(1): 56-65, doi: 10.1007/s00120-022-01975-5


5.    Braulke F, Kober K, Arndt A, Papendick M, Strauss A, Kramm CM, Thoms KM, König A, Gaedcke J, Gallwas J, Wulf S, Szuszies C, Wulf G, Rödel R, Wolfer S, Malinova V, Overbeck TR, Hinterthaner M, Lotz J, Nauck F, Ernst M, Stadelmann C, Ströbel P, Ellenrieder V, Asendorf T, Rieken S (2023) Optimizing the structure of interdisciplinary tumor boards for effective cancer care. FRONT ONCOL 13: 1072652, doi: 10.3389/fonc.2023.1072652


6.    Gayer FA, Henkel M, Luft J, Reichardt SD, Fichtner A, Legler TJ, Reichardt HM (2023) The Subtype Identity of Testicular Cancer Cells Determines Their Immunostimulatory Activity in a Coculture Model. CANCERS 15(9): 2619, doi: 10.3390/cancers15092619


7.    Groeben C, Boehm K, Koch R, Sonntag U, Nestler T, Struck J, Heck M, Baunacke M, Uhlig A, Koelker M, Meyer CP, Becker B, Salem J, Huber J, Leitsmann M (2023) Hospital rating websites play a minor role for uro-oncologic patients when choosing a hospital for major surgery: results of the German multicenter NAVIGATOR-study. WORLD J UROL 41(2): 601-609, doi: 10.1007/s00345-022-04271-1


8.    Leitsmann C, Uhlig A, Bremmer F, Mohr MN, Trojan L, Leitsmann M, Reichert M (2023) Impact of multiparametric magnetic resonance imaging targeted biopsy on functional outcomes in patients following robot-assisted laparoscopic radical prostatectomy. FRONT SURG 10: 1305365, doi: 10.3389/fsurg.2023.1305365


9.    Mikuteit M, Zschäbitz S, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Duensing S, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos F, Walter B, Otto W, Burger M, Erlmeier M, Schrader AJ, Hartmann A, Erlmeier F, Steffens S, German Network Of Kidney Cancer (2023) Evaluation of Gas 6 as a Prognostic Marker in Papillary Renal Cell Carcinoma. UROL INT 107(7): 713-722, doi: 10.1159/000529898


10.    Mohr MN, Uhlig A, Ploeger HM, Hahn O, Trojan L, Reichert M (2023) The influence of secondary resection using NeuroSAFE-technique on sexual function in unilateral nerve-sparing robot-assisted laparoscopic prostatectomies. SCAND J UROL 58: 60-67, doi: 10.2340/sju.v58.6234


11.    Mohr MN, Uhlig A, Strauß A, Leitsmann C, Ahyai SA, Trojan L, Reichert M (2023) Prospective evaluation of an intraoperative urodynamic stress test predicting urinary incontinence after robot-assisted laparoscopic radical prostatectomy. Urol Ann 15(2): 166-173, doi: 10.4103/ua.ua_47_22


12.    Reichert M, Schüler P, Stepniewski A, Felmerer G, Trojan L, von Knobloch HC (2023) [Closure of persisting rectourethral fistula after suprasymphyseal adenoma enucleation of the prostate by combining the Bressel-Naujox and gracilis flap procedure]. Urologie 62(3): 295-298, doi: 10.1007/s00120-022-01924-2


13.    Reichert M, Stepniewski A, Grade M, Felmerer G, Trojan L, Mohr MN (2023) [Closure of a prostatocutaneous urinary fistula while preserving sexual function using a perineal approach with Gracilis flap interposition]. AKTUEL UROL -(-): -, doi: 10.1055/a-2201-6302


14.    Schneidewind L, Kiss B, Zengerling F, Borkowetz A, Graf S, Kranz J, Dräger DL, Graser A, Bellut L, Uhlig A (2023) Gender-specific outcomes in immune checkpoint inhibitor therapy for advanced or metastatic urothelial cancer: a systematic review and meta-analysis. J CANCER RES CLIN 149(11): 9399-9408, doi: 10.1007/s00432-023-04788-x


15.    Uhlig A (2023) [Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to prostatic hyperplasia]. Urologie 62(11): 1211-1214, doi: 10.1007/s00120-023-02207-0


16.    Uhlig A, Uhlig J, Woike M, Fischer T, Trojan L, Lothar L, Bögemann M, Goebell PJ, Rink M, Schlack K, Marianne M, Strauß A (2023) Axitinib beyond first-line therapy of Metastatic Renal Cell Carcinoma: Real World Data from the STAR-TOR registry. Kidney Cancer 7: 37-48

Publikationen 2022

1.    Aksoy C, Reimold P, Borgmann H, Kölker M, Cebulla A, Struck JP, Zehe V, Nestler T, von Landenberg N, Uhlig A, Boehm K, Leitsmann M (2022) [Impact of the COVID-19 pandemic on urology residency training programs in Germany]. AKTUEL UROL 53(4): 317, doi: 10.1055/a-1824-4288


2.    Erlmeier F, Bruecher B, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Hartmann A, Mondorf Y, Ivanyi P, Mikuteit M, Steffens S, German Network Of Kidney Cancer (2022) cMET: a prognostic marker in papillary renal cell carcinoma? HUM PATHOL 121: 1, doi: 10.1016/j.humpath.2021.12.007


3.    Grünwald V, Hilser T, Meiler J, Goebell PJ, Ivanyi P, Strauss A, Hartmann A, Bedke J, Bergmann L (2022) A Prospectivly Randomized Phase-II Trial of Axitinib versus Everolimus as Second-Line Therapy in Metastatic Renal Cell Carcinoma (BERAT Study). ONCOL RES TREAT 45(5): 272, doi: 10.1159/000522043


4.    Harke NN, Wagner C, Hermann RM, Hadaschik BA, Radtke JP, Altay-Langguth A, Aufderklamm S, Bach C, Becker-Schiebe M, Blana A, Bruns F, Buse S, Combs SE, Engels CL, Ezzibdeh E, Fiedler M, Fischer LA, Farzat M, Frismann A, Heck MM, Henkenberens C, Roesch MC, Käding C, Klautke G, Krausewitz P, Kuczyk MA, Leitsmann C, Lettmaier S, Mahjoub S, Manseck A, Medenwald D, Meyer A, Micke O, Moritz R, Ott M, Peters I, Pokupic S, Porres D, Preisser F, Reichel K, Schneider A, Schwentner C, Scobioala S, Truss M, Wegener D, Wezel F, Willborn K, Witt JH, Wittig A, Wittlinger M, Wolff HA, Zimmermanns V, Christiansen H (2022) Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: A German survey on prostate cancer diagnosis and treatment. PLOS ONE 17(6): e0269827, doi: 10.1371/journal.pone.0269827


5.    Hoeh B, Schmucker P, Klümper N, Hahn O, Zeuschner P, Banek S, Karakiewicz PI, Ellinger J, Heinzelbecker J, Hölzel M, Strauß A, Zengerling F, Mattigk A, Kalogirou C (2022) Comparison of First-Line Anti-PD-1-Based Combination Therapies in Metastatic Renal-Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort. UROL INT 106(11): 1150, doi: 10.1159/000521661


6.    Klümper N, Ralser DJ, Ellinger J, Roghmann F, Albrecht J, Below E, Alajati A, Sikic D, Breyer J, Bolenz C, Zengerling F, Erben P, Schwamborn K, Wirtz RM, Horn T, Nagy D, Toma M, Kristiansen G, Büttner T, Hahn O, Grünwald V, Darr C, Erne E, Rausch S, Bedke J, Schlack K, Abbas M, Zschäbitz S, Schwab C, Mustea A, Adam P, Manseck A, Wullich B, Ritter M, Hartmann A, Gschwend J, Weichert W, Erlmeier F, Hölzel M, Eckstein M (2022) Membranous NECTIN-4 expression frequently decreases during metastatic spread of urothelial carcinoma and is associated with enfortumab vedotin resistance. CLIN CANCER RES -: -, doi: 10.1158/1078-0432.CCR-22-1764


7.    Lebentrau S, Wolff I, Hempel MC, Haccius M, Kluth LA, Pycha A, Brookman-May S, Schneider TR, Hermanns T, Distler FA, Boegemann M, Kübler H, Shariat SF, Burger M, May M (2022) [Knowledge of German-speaking urologists regarding the association between penile cancer and human papilloma virus: results of a survey of the European PROspective Penile Cancer Study (E-PROPS)]. AKTUEL UROL 53(5): 461, doi: 10.1055/a-1032-8086


8.    Lehrke J, Boos M, Cordes A, Leitsmann C, Friedrich M (2022) Effects of a Technical Solution on Stress of Surgical Staff in Operating Theatres. THORAC CARDIOV SURG 70(5): 392, doi: 10.1055/s-0041-1741059


9.    Leitsmann C, Uhlig A, Bremmer F, Mut TT, Ahyai S, Reichert M, Leitsmann M, Trojan L, Popeneciu IV (2022) Impact of mpMRI targeted biopsy on intraoperative nerve-sparing (NeuroSAFE) during robot-assisted laparoscopic radical prostatectomy. PROSTATE 82(4): 493, doi: 10.1002/pros.24295


10.    Lisney AR, Leitsmann C, Strauß A, Meller B, Bucerius JA, Sahlmann CO (2022) The Role of PSMA PET/CT in the Primary Diagnosis and Follow-Up of Prostate Cancer-A Practical Clinical Review. CANCERS 14(15): -, doi: 10.3390/cancers14153638


11.    Mikuteit M, Zschäbitz S, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Hartmann A, Steffens S, Erlmeier F (2022) The prognostic impact of Claudin 6 in papillary renal cell carcinoma. PATHOL RES PRACT 231: 153802, doi: 10.1016/j.prp.2022.153802


12.    Mondorf Y, Mikuteit M, Ivanyi P, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief CG, Haferkamp A, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Hartmann A, Steffens S, Erlmeier F (2022) The Prognostic Impact of PD-L2 in Papillary Renal-Cell Carcinoma. UROL INT 106(11): 1168, doi: 10.1159/000525016


13.    Oh-Hohenhorst SJ, Tilki D, Ahlers AK, Suling A, Hahn O, Tennstedt P, Matuszcak C, Maar H, Labitzky V, Hanika S, Starzonek S, Baumgart S, Johnsen SA, Kluth M, Sirma H, Simon R, Sauter G, Huland H, Schumacher U, Lange T (2022) CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivo. CANCER GENE THER 29(1): 49-61, doi: 10.1038/s41417-020-00288-z


14.    Reichert M, Aragona M, Soukkar A, Olianas R (2022) Mesh Graft Urethroplasty-Still a Safe and Promising Technique in Mostly Unpromising Complex Urethral Strictures. J CLIN MED 11(20): -, doi: 10.3390/jcm11205989


15.    Reichert M, Ploeger HM, Uhlig A, Strauss A, Henniges P, Trojan L, Mohr MN (2022) Understanding long-term continence rates after robot-assisted laparoscopic prostatectomy - one-year follow-up on "Cognitive ability as a non-modifiable risk factor for post-prostatectomy urinary incontinence". FRONT SURG 9: 1055880, doi: 10.3389/fsurg.2022.1055880


16.    Reichert M, Strauss A, Mohr MN, Schneider TR, Trojan L, Hahn O (2022) [A noteworthy case: An atypically located urachal cyst after continent urinary diversion using a MAINZ pouch with an appendix stoma]. AKTUEL UROL -: -, doi: 10.1055/a-1909-5871


17.    Uhlig A, Baunacke M, Groeben C, Borkowetz A, Volkmer B, Ahyai SA, Trojan L, Eisenmenger N, Schneider A, Thomas C, Huber J, Leitsmann M (2022) [Contemporary surgical management of benign prostatic obstruction in Germany: A population-wide study based on German hospital quality report data from 2006 to 2019]. UROLOGE 61(5): 508, doi: 10.1007/s00120-022-01777-9


18.    Uhlig J, Uhlig A, Bachanek S, Onur MR, Kinner S, Geisel D, Köhler M, Preibsch H, Puesken M, Schramm D, May M, De Visschere P, Weber MA, Surov A (2022) Primary renal sarcomas: imaging features and discrimination from non-sarcoma renal tumors. EUR RADIOL 32(2): 981, doi: 10.1007/s00330-021-08201-4


19.    Wu X, Uhlig J, Shuch BM, Uhlig A, Kim HS (2022) Cost-effectiveness of minimally invasive partial nephrectomy and percutaneous cryoablation for cT1a renal cell carcinoma. EUR RADIOL -: -, doi: 10.1007/s00330-022-09211-6


20.    Zschäbitz S, Erlmeier F, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Mondorf Y, Hartmann A, Ivanyi P, Steffens S (2022) Expression of Prostate-specific Membrane Antigen (PSMA) in Papillary Renal Cell Carcinoma - Overview and Report on a Large Multicenter Cohort. J CANCER 13(6): 1706, doi: 10.7150/jca.63509


21.    Zschäbitz S, Mikuteit M, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Duensing S, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Hartmann A, Erlmeier F, Steffens S (2022) Expression of nectin-4 in papillary renal cell carcinoma. Discov Oncol 13(1): 90, doi: 10.1007/s12672-022-00558-2
 
 

Publikationen 2021

1.    Baunacke M, Groeben C, Borkowetz A, Uhlig A, Leitsmann M, Volkmer B, Thomas C, Huber J (2021) [Health care reality of urological endoprosthetics in Germany from 2006 to 2016]. UROLOGE -: -, doi: 10.1007/s00120-021-01444-5


2.    Boehm K, Borgmann H, Ebert T, Höfner T, Khaljani E, Schmid M, Schulze-Seemann W, Weib P, Herden J (2021) Stage and Grade Migration in Prostate Cancer Treated With Radical Prostatectomy in a Large German Multicenter Cohort. CLIN GENITOURIN CANC 19(2): 162-166.e1, doi: 10.1016/j.clgc.2020.12.004


3.    Erlmeier F, Steffens S, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Hartmann A, Ivanyi P, (German Network Of Kidney Cancer) (2021) Characterization of PD-1 and PD-L1 Expression in Papillary Renal Cell Carcinoma: Results of a Large Multicenter Study. CLIN GENITOURIN CANC 19(1): 53-59.e1, doi: 10.1016/j.clgc.2020.07.002


4.    Graf S, Kranz J, Schmidt S, Bellut L, Uhlig A (2021) [Types of evidence syntheses]. UROLOGE 60(4): 434-443, doi: 10.1007/s00120-021-01476-x


5.    Klümper N, Ralser DJ, Zarbl R, Schlack K, Schrader AJ, Rehlinghaus M, Hoffmann MJ, Niegisch G, Uhlig A, Trojan L, Steinestel J, Steinestel K, Wirtz RM, Sikic D, Eckstein M, Kristiansen G, Toma M, Hölzel M, Ritter M, Strieth S, Ellinger J, Dietrich D (2021) CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma. J IMMUNOTHER CANCER 9(8): -, doi: 10.1136/jitc-2021-002949


6.    Klümper N, Schmucker P, Hahn O, Höh B, Mattigk A, Banek S, Ellinger J, Heinzelbecker J, Sikic D, Eckstein M, Strauß A, Zengerling F, Hölzel M, Zeuschner P, Kalogirou C (2021) C-reactive protein flare-response predicts long-term efficacy to first-line anti-PD-1-based combination therapy in metastatic renal cell carcinoma. CLIN TRANSL IMMUNOL 10(12): e1358, doi: 10.1002/cti2.1358


7.    Leitsmann C, Schmid M, Sahlmann CO, Trojan L, Strauss A (2021) Mesorectal Lymph Node Metastases as Index Lesion in 68 Ga-PSMA-PET/CT Imaging for Recurrent Prostate Cancer. FRONT SURG 8: 637134, doi: 10.3389/fsurg.2021.637134


8.    Meyer-Lamp I, Boos M, Schugmann LS, Leitsmann C, Trojan L, Friedrich MG (2021) Silent operating theatre optimisation system for positive impact on surgical staff-members' stress, exhaustion, activity and concentration in urological da Vinci surgeries. BMJ Innovations 7: 175-184


9.    Mut TT, Acar Ö, Armutlu A, Incir S, Uhlig A, Ertuglu LA, Özel M, Taskin AC, Baydar DE, Kanbay M, Esen T (2021) Can remote ischemic preconditioning counteract the renal functional deterioration attributable to partial nephrectomy under warm ischemia? Results of an animal study. BMC NEPHROL 22(1): 266, doi: 10.1186/s12882-021-02359-1


10.    Neumann JM, Niehaus K, Neumann N, Knobloch HC, Bremmer F, Krafft U, Kellner U, Nyirády P, Szarvas T, Bednarz H, Reis H (2021) A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer. LAB INVEST 101(9): 1281-1288, doi: 10.1038/s41374-021-00612-7


11.    Reichert M, Popeneciu IV, Uhlig A, Trojan L, Mohr MN (2021) Cognitive Ability as a Non-modifiable Risk Factor for Post-prostatectomy Urinary Incontinence: A Double-Blinded, Prospective, Single-Center Trial. FRONT SURG 8: 812197, doi: 10.3389/fsurg.2021.812197


12.    Rücker F, Lehrich K, Böhme A, Zacharias M, Ahyai SA, Hansen J (2021) A call for HoLEP: en-bloc vs. two-lobe vs. three-lobe. WORLD J UROL -: -, doi: 10.1007/s00345-021-03598-5


13.    Seidel C, Daugaard G, Nestler T, Tryakin A, Fedyanin M, Fankhauser CD, Hermanns T, Aparicio J, Heinzelbecker J, Paffenholz P, Heidenreich A, De Giorgi U, Cathomas R, Lorch A, Fingerhut A, Gayer F, Bremmer F, Giannatempo P, Necchi A, Raggi D, Aurilio G, Casadei C, Hentrich M, Tran B, Dieckmann KP, Brito M, Ruf C, Mazzocca A, Vincenzi B, Stahl O, Bokemeyer C, Oing C (2021) The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3). WORLD J UROL 39(9): 3407-3414, doi: 10.1007/s00345-021-03635-3


14.    Strauss A, Schmid M, Rink M, Moran M, Bernhardt S, Hubbe M, Bergmann L, Schlack K, Boegemann M (2021) Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry. FUTURE ONCOL 17(18): 2325-2338, doi: 10.2217/fon-2020-1020


15.    Treiber H, König A, Neesse A, Richter A, Sahlmann CO, Strauss A (2021) Liver Enzyme Elevation After 177 Lu-PSMA Radioligand Therapy for Metastasized Castration-Resistant Prostate Cancer. J NUCL MED 62(7): 1016-1019, doi: 10.2967/jnumed.120.258533


16.    Tunc L, Bozzini G, Scoffone CM, Guven S, Hermann T, Porreca A, Misrai V, Ahyai S, Zor M, Aksoy E, Gozen AS (2021) Determination of Face and Content Validity of Cadaveric Model for Holmium Anatomic Endoscopic Enucleation of the Prostate Training: An ESUT AEEP Group Study. Eur Urol Open Sci 32: 28-34, doi: 10.1016/j.euros.2021.07.005


17.    Uhlig A (2021) [Are there gender-specific differences in the efficacy of pain management with opioids?: Results of a systematic review with meta-analysis]. UROLOGE 60(7): 939-942, doi: 10.1007/s00120-021-01553-1


18.    Uhlig A, Uhlig J, Trojan L, Woike M, Leitsmann M, Strauß A (2021) Toxicities of axitinib, sunitinib and temsirolimus: implications for progression-free and overall survival in metastatic renal cell cancer. FUTURE ONCOL 17(1): 45-56, doi: 10.2217/fon-2020-0900


19.    Wenzel M, Kleimaker A, Uhlig A, Würnschimmel C, Becker A, Yu H, Meyer CP, Fisch M, Chun FKH, Leitsmann M (2021) Impact of comorbidities on acute kidney injury and renal function impairment after partial and radical tumor nephrectomy. SCAND J UROL 55(5): 377-382, doi: 10.1080/21681805.2021.1948916


20.    Wenzel M, Welte MN, Grossmann L, Preisser F, Theissen LH, Humke C, Deuker M, Bernatz S, Gild P, Ahyai S, Karakiewicz PI, Bodelle B, Kluth LA, Chun FKH, Mandel P, Becker A (2021) Multiparametric MRI may Help to Identify Patients With Prostate Cancer in a Contemporary Cohort of Patients With Clinical Bladder Outlet Obstruction Scheduled for Holmium Laser Enucleation of the Prostate (HoLEP). FRONT SURG 8: 633196, doi: 10.3389/fsurg.2021.633196


21.    Wenzel M, Yu H, Uhlig A, Würnschimmel C, Wallbach M, Becker A, Fisch M, Chun FKH, Meyer CP, Leitsmann M (2021) Cystatin C predicts renal function impairment after partial or radical tumor nephrectomy. INT UROL NEPHROL 53(10): 2041-2049, doi: 10.1007/s11255-021-02957-w
 

Publikationen 2020

  1. Ahyai SA, Marik I, Ludwig TA, Becker A, Asdjodi S, Kluth L, Chun F, Fisch M, Schmid M (2020) Super early detailed assessment of lower urinary tract symptoms after holmium laser enucleation of the prostate (HoLEP): a prospective study. WORLD J UROL -: -, doi: 10.1007/s00345-020-03126-x
  2. Boegemann M, Schlack K, Rink M, Bernhardt S, Moran M, Hubbe M, Bergmann L, Schmid M, Strauss A (2020) Effect of comorbidities/comedications on sunitinib outcomes for metastatic renal cell carcinoma: the STAR-TOR registry. FUTURE ONCOL -: -, doi: 10.2217/fon-2020-0548
  3. Erlmeier F, Steffens S, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Hartmann A, Ivanyi P, (German Network Of Kidney Cancer) (2020) Characterization of PD-1 and PD-L1 Expression in Papillary Renal Cell Carcinoma: Results of a Large Multicenter Study. CLIN GENITOURIN CANC -: -, doi: 10.1016/j.clgc.2020.07.002
  4. Fichtner A, Richter A, Filmar S, Gaisa NT, Schweyer S, Reis H, Nettersheim D, Oing C, Gayer FA, Leha A, Küffer S, Ströbel P, Kaulfuß S, Bremmer F (2020) The detection of isochromosome i[12p] in malignant germ cell tumours and tumours with somatic malignant transformation using qPCR. HISTOPATHOLOGY -: -, doi: 10.1111/his.14258
  5. Gild P, Dahlem R, Pompe RS, Soave A, Vetterlein MW, Ludwig TA, Maurer V, Marks P, Ahyai SA, Chun FKH, Lenke L, Ernst T, Fisch M, Rink M, Meyer CP, Becker A (2020) Retrograde ejaculation after holmium laser enucleation of the prostate (HoLEP)-Impact on sexual function and evaluation of patient bother using validated questionnaires. ANDROLOGY-US -: -, doi: 10.1111/andr.12887
  6. Gild P, Lenke L, Pompe RS, Vetterlein MW, Ludwig TA, Soave A, Chun F, Ahyai SA, Dahlem R, Fisch M, Rink M, Meyer C, Becker A (2020) Assessing the outcome of Holmium Laser Enucleation of the Prostate (HoLEP) by age, prostate volume, and a history of blood thinning agents - report from a single-center series of >1,800 consecutive cases. J ENDOUROL -: -, doi: 10.1089/end.2020.0605
  7. Hahn O, Heining FM, Janzen J, Becker JCR, Bertlich M, Thelen P, Mansour JJ, Duensing S, Pahernik S, Trojan L, Popeneciu IV(2020) Modulating the Heat Sensitivity of Prostate Cancer Cell Lines In Vitro: A New Impact for Focal Therapies. Biomedicines 8(12): -, doi: 10.3390/biomedicines8120585
  8. König F, Strauß A, Johannsen M, Mommsen C, Fricke E, Klier J, Mehl S, Pfister D, Sahlmann CO, Werner A, Goebell PJ (2020) [Radium-223 for the treatment of metastatic castration-resistant prostate cancer (mCRPC): The androgen receptor-independent active agent in the therapeutic sequence]. UROLOGE 59(1): 53-64, doi: 10.1007/s00120-019-01052-4
  9. Kriegmair MC, Younsi N, Hiller K, Leitsmann C, Kowalewski KF, Siegel F, Rothamel M, Ritter M, Bolenz C, Kriegmair M, Trojan L, Michel MS (2020) Single- vs multiple-layer wound closure for flank incisions: results of a prospective, randomised, double-blinded multicentre study. BJU INT -: -, doi: 10.1111/bju.15148
  10. Leitsmann C, Uhlig A, Popeneciu IV, Boos M, Ahyai SA, Schmid M, Wachter R, Trojan L, Friedrich M (2020) The Silent Operation Theatre Optimisation System (SOTOS©) to reduce noise pollution during da Vinci robot-assisted laparoscopic radical prostatectomy.J Robot Surg -: -, doi: 10.1007/s11701-020-01135-x
  11. Seidel C, Daugaard G, Nestler T, Tryakin A, Fedyanin M, Fankhauser C, Hermanns T, Aparicio J, Heinzelbecker J, Paffenholz P, Heidenreich A, De Giorgi U, Cathomas R, Lorch A, Fingerhut A, Gayer F, Bremmer F, Giannatempo P, Necchi A, Aurilio G, Casadei C, Tran B, Dieckmann KP, Brito M, Ruf C, Oing C, Bokemeyer C (2020) Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3). EUR J CANCER 132: 127-135, doi: 10.1016/j.ejca.2020.03.022
  12. Trojan L, Conrad S (2020) [New Section: Urological Care]. UROLOGE 59(5): 613, doi: 10.1007/s00120-020-01219-4
  13. Uhlig A (2020) [Do men and women respond differently to pain therapy with opioids? Results of a meta-analysis]. UROLOGE 59(7): 835-838, doi: 10.1007/s00120-020-01247-0
  14. Uhlig A, Uhlig J, Trojan L, Kim HS (2020) Stereotactic Body Radiotherapy for Stage I Renal Cell Carcinoma: National Treatment Trends and Outcomes Compared to Partial Nephrectomy and Thermal Ablation. J VASC INTERV RADIOL 31(4): 564-571, doi: 10.1016/j.jvir.2019.11.009
  15. Uhlig A, Uhlig J, Trojan L, Woike M, Leitsmann M, Strauß A (2020) Toxicities of axitinib, sunitinib and temsirolimus: implications for progression-free and overall survival in metastatic renal cell cancer. FUTURE ONCOL -: -, doi: 10.2217/fon-2020-0900
  16. Uhlig J, Biggemann L, Nietert MM, Beißbarth T, Lotz J, Kim HS, Trojan L, Uhlig A (2020) Discriminating malignant and benign clinical T1 renal masses on computed tomography: A pragmatic radiomics and machine learning approach. MEDICINE 99(16): e19725, doi: 10.1097/MD.0000000000019725
  17. Uhlig J, Leha A, Delonge LM, Haack AM, Shuch B, Kim HS, Bremmer F, Trojan L, Lotz J, Uhlig A (2020) Radiomic Features and Machine Learning for the Discrimination of Renal Tumor Histological Subtypes: A Pragmatic Study Using Clinical-Routine Computed Tomography. CANCERS 12(10): -, doi: 10.3390/cancers12103010

Publikationen 2019

  1. Bremmer F, Bohnenberger H, Küffer S, Oellerich T, Serve H, Urlaub H, Strauss A, Maatoug Y, Behnes CL, Oing C, Radzun HJ, Ströbel P, Balabanov S, Honecker F (2019) Proteomic Comparison of Malignant Human Germ Cell Tumor Cell Lines. DIS MARKERS 2019: 8298524, doi: 10.1155/2019/8298524
  2. Kauffels-Sprenger A, Lehmann W, Kutschka I, Trojan L, Ghadimi M (2019) [The Joy of Being a Surgeon - How to Generate Enthusiasm in Undergraduate Medical Education - A Local Example: The "Göttinger Aufschneidertag"]. ZBL CHIR 144(6): 614-615, doi: 10.1055/a-1007-2062
  3. Leitsmann C, Thelen P, Schmid M, Meller J, Sahlmann CO, Meller B, Trojan L, Strauss A (2019) Enhancing PSMA-uptake with androgen deprivation therapy - a new way to detect prostate cancer metastases? Int Braz J Urol 45(3): 459-467, doi: 10.1590/S1677-5538.IBJU.2018.0305
  4. Pellkofer H, Ihler F, Weiss BG, Trothe J, Kadavath H, Chongtham M, Kunadt M, Riedel D, Lornsen F, Wilken P, Bartels C, Hirschel S, Russo SG, Stransky E, Trojan L, Schmidt B, Mandelkow E, Zweckstetter M, Canis M, Schneider A (2019) Evaluation of the methoxy-X04 derivative BSC4090 for diagnosis of prodromal and early Alzheimer's disease from bioptic olfactory mucosa. EUR ARCH PSY CLIN N 269(8): 973-984, doi: 10.1007/s00406-018-0955-6
  5. Peyronnet B, O'Connor E, Khavari R, Capon G, Manunta A, Allue M, Hascoet J, Nitti VW, Gamé X, Gilleran J, Castro-Sader L, Cornu JN, Waltregny D, Ahyai S, Chung E, Elliott DS, Fournier G, Brucker BM (2019) AMS-800 Artificial urinary sphincter in female patients with stress urinary incontinence: A systematic review. NEUROUROL URODYNAM 38 Suppl 4: S28-S41, doi: 10.1002/nau.23833
  6. Polifka I, Agaimy A, Herrmann E, Spath V, Trojan L, Stöckle M, Becker F, Ströbel P, Wülfing C, Schrader AJ, Barth P, Staehler M, Stief C, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Höfler H, Haferkamp A, Geppert CI, Stöhr C, Hartmann A, German Network Of Kidney Cancer (2019) High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma. HUM PATHOL 83: 212-223, doi: 10.1016/j.humpath.2018.08.006
  7. Schmid M, Wallbach M (2019) Editorial Comment from Dr Schmid and Dr Wallbach to Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy. INT J UROL 26(1): 118-119, doi: 10.1111/iju.13815
  8. Seif Amir Hosseini A, Uhlig J, Streit U, Uhlig A, Sprenger T, Wedi E, Ellenrieder V, Ghadimi M, Uecker M, Voit D, Frahm J, Lotz J, Biggemann L (2019) Hiatal hernias in patients with GERD-like symptoms: evaluation of dynamic real-time MRI vs endoscopy.EUR RADIOL 29(12): 6653-6661, doi: 10.1007/s00330-019-06284-8
  9. Seif Amir Hosseini A, Uhlig J, Streit U, Voit D, Uhlig A, Ellenrieder V, Ghadimi M, Sprenger T, Beham A, Uecker M, Frahm J, Lotz J, Biggemann L (2019) Real-time MRI for the dynamic assessment of fundoplication failure in patients with gastroesophageal reflux disease. EUR RADIOL 29(9): 4691-4698, doi: 10.1007/s00330-019-06025-x
  10. Seseke S, Leitsmann C, Hijazi S, Trojan L, Dechent P (2019) Functional MRI in patients with detrusor sphincter dyssynergia: Is the neural circuit affected? NEUROUROL URODYNAM 38(8): 2104-2111, doi: 10.1002/nau.24112
  11. Strauss A, Uhlig J, Lotz J, Trojan L, Uhlig A (2019) Tumor laterality in renal cancer as a predictor of survival in large patient cohorts: A STROBE compliant study. MEDICINE 98(17): e15346, doi: 10.1097/MD.0000000000015346
  12. Tutolo M, Cornu JN, Bauer RM, Ahyai S, Bozzini G, Heesakkers J, Drake MJ, Tikkinen KAO, Launonen E, Larré S, Thiruchelvam N, Lee R, Li P, Favro M, Zaffuto E, Bachmann A, Martinez-Salamanca JI, Pichon T, De Nunzio C, Ammirati E, Haab F, Van Der Aa F (2019) Efficacy and safety of artificial urinary sphincter (AUS): Results of a large multi-institutional cohort of patients with mid-term follow-up. NEUROUROL URODYNAM 38(2): 710-718, doi: 10.1002/nau.23901
  13. Uhlig A (2019) [Tumor treatment of metastatic renal cell carcinoma: Comparison of immunotherapy with other drug options].UROLOGE 58(10): 1208-1211, doi: 10.1007/s00120-019-01038-2
  14. Uhlig A, Uhlig J, Gröben C, Huber J, Schmid M (2019) [Public online reporting of urological content for hospital choice making in Germany: a systematic overview]. AKTUEL UROL 50(4): 398-406, doi: 10.1055/a-0879-8049
  15. Uhlig A, Uhlig J, Trojan L, Hinterthaner M, von Hammerstein-Equord A, Strauss A (2019) Surgical approaches for treatment of ureteropelvic junction obstruction - a systematic review and network meta-analysis. BMC UROL 19(1): 112, doi: 10.1186/s12894-019-0544-7
  16. Uhlig J, Strauss A, Rücker G, Seif Amir Hosseini A, Lotz J, Trojan L, Kim HS, Uhlig A (2019) Partial nephrectomy versus ablative techniques for small renal masses: a systematic review and network meta-analysis. EUR RADIOL 29(3): 1293-1307, doi: 10.1007/s00330-018-5660-3
  17. Uhlig J, Uhlig A, Biggemann L, Fischer U, Lotz J, Wienbeck S (2019) Diagnostic accuracy of cone-beam breast computed tomography: a systematic review and diagnostic meta-analysis. EUR RADIOL 29(3): 1194-1202, doi: 10.1007/s00330-018-5711-9
  18. Vorobyev A, Gupta Y, Sezin T, Koga H, Bartsch YC, Belheouane M, Künzel S, Sina C, Schilf P, Körber-Ahrens H, Beltsiou F, Lara Ernst A, Khil'chenko S, Al-Aasam H, Manz RA, Diehl S, Steinhaus M, Jascholt J, Kouki P, Boehncke WH, Mayadas TN, Zillikens D, Sadik CD, Nishi H, Ehlers M, Möller S, Bieber K, Baines JF, Ibrahim SM, Ludwig RJ (2019) Gene-diet interactions associated with complex trait variation in an advanced intercross outbred mouse line. NAT COMMUN 10(1): 4097, doi: 10.1038/s41467-019-11952-w
  19. Wilhelm K, Hahn O, Schoenthaler M, Hein S, Neubauer J, Schnabel M, Neisius A (2019) Stone-Free Rate after Treating Kidney Stones Exceeding 10 mm via Flexible Ureteroscopy: Can Endoscopic Assessment Replace Low-Dose Computed Tomography Control? UROL INT 103(3): 326-330, doi: 10.1159/000502264
  20. Withington J, Cole AP, Meyer CP, Seisen T, Schmid M, Lipsitz SR, Sweeney CJ, Dasgupta P, Trinh QD (2019) Comparison of testis cancer-specific survival: an analysis of national cancer registry data from the USA, UK and Germany. BJU INT 123(3): 385-387, doi: 10.1111/bju.14616

Publikationen 2018

  1. Borgmann H, Salem J, Baunacke M, Boehm K, Groeben C, Schmid M, Siegel FP, Huber J (2018) Mapping the landscape of urology: A new media-based cross-sectional analysis of public versus academic interest. INT J UROL 25(5): 421-428, doi: 10.1111/iju.13527
  2. Bremmer F, Jarry H, Unterkircher V, Kaulfuss S, Burfeind P, Radzun HJ, Ströbel P, Thelen P (2018) Testosterone metabolites inhibit proliferation of castration- and therapy-resistant prostate cancer. ONCOTARGET 9(24): 16951-16961, doi: 10.18632/oncotarget.24763
  3. Buergy D, Schneiberg V, Schaefer J, Welzel G, Trojan L, Bolenz C, Wenz F (2018) Quality of life after low-dose rate-brachytherapy for prostate carcinoma - long-term results and literature review on QLQ-C30 and QLQ-PR25 results in published brachytherapy series. HEALTH QUAL LIFE OUT 16(1): 21, doi: 10.1186/s12955-018-0844-8
  4. Groeben C, Koch R, Baunacke M, Schmid M, Borkowetz A, Wirth MP, Huber J (2018) Urinary Diversion After Radical Cystectomy for Bladder Cancer: Comparing Trends in the US and Germany from 2006 to 2014. ANN SURG ONCOL n.a.: n.a., doi: 10.1245/s10434-018-6381-1
  5. Hubert J, Weiser L, Hischke S, Uhlig A, Rolvien T, Schmidt T, Butscheidt SK, Püschel K, Lehmann W, Beil FT, Hawellek T (2018) Cartilage calcification of the ankle joint is associated with osteoarthritis in the general population. BMC MUSCULOSKEL DIS 19(1): 169, doi: 10.1186/s12891-018-2094-7
  6. Küffer S, Gutting T, Belharazem D, Sauer C, Michel MS, Marx A, Trojan L, Ströbel P (2018) Insulin-like growth factor 2 expression in prostate cancer is regulated by promoter-specific methylation. MOL ONCOL 12(2): 256-266, doi: 10.1002/1878-0261.12164
  7. Martinschek A, Welzel G, Ritter M, Heinrich E, Bolenz C, Trojan L (2018) The concentration of console surgeons: prospective evaluation of the loss of attention in robotic-assisted procedures. J Robot Surg n.a.: n.a., doi: 10.1007/s11701-018-0800-y
  8. Polifka I, Agaimy A, Herrmann E, Spath V, Trojan L, Stöckle M, Becker F, Ströbel P, Wülfing C, Schrader AJ, Barth P, Staehler M, Stief C, Hohenfellner M, Macher-Göppinger S, Höfler H, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Haferkamp A, Geppert CI, Stöhr C, Hartmann A, German Network Of Kidney Cancer (2018) High proliferation rate and TNM-stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma. HUM PATHOL n.a.: n.a., doi: 10.1016/j.humpath.2018.08.006
  9. Seif Amir Hosseini A, Beham A, Uhlig J, Streit U, Uhlig A, Ellenrieder V, Joseph AA, Voit D, Frahm J, Uecker M, Lotz J, Biggemann L (2018) Intra- and interobserver variability in the diagnosis of GERD by real-time MRI. EUR J RADIOL 104: 14-19, doi: 10.1016/j.ejrad.2018.04.029
  10. Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, Olmos D, Mainwaring PN, Lee JY, Uemura H, Lopez-Gitlitz A, Trudel GC, Espina BM, Shu Y, Park YC, Rackoff WR, Yu MK, Small EJ, SPARTAN Investigators (2018) Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer. NEW ENGL J MED 378(15): 1408-1418, doi: 10.1056/NEJMoa1715546
  11. Soave A, Dahlem R, Pinnschmidt HO, Rink M, Langetepe J, Engel O, Kluth LA, Loechelt B, Reiss P, Ahyai SA, Fisch M (2018) Substitution Urethroplasty with Closure Versus Nonclosure of the Buccal Mucosa Graft Harvest Site: A Randomized Controlled Trial with a Detailed Analysis of Oral Pain and Morbidity. EUR UROL 73(6): 910-922, doi: 10.1016/j.eururo.2017.11.014
  12. Tahbaz R, Schmid M, Merseburger AS (2018) Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutrition. CURR OPIN UROL 28(1): 62-79, doi: 10.1097/MOU.0000000000000454
  13. Thelen P, Taubert H, Duensing S, Kristiansen G, Merseburger AS, Cronauer MV (2018) [The impact of the androgen receptor splice variant AR-V7 on the prognosis and treatment of advanced prostate cancer]. AKTUEL UROL n.a.: n.a., doi: 10.1055/s-0043-115426
  14. Uhlig A (2018) [Strategies to reduce patient loss during the follow-up period of randomized trials]. UROLOGE 57(5): 601-604, doi: 10.1007/s00120-018-0639-x
  15. Uhlig A, Behnes CL, Strauss A, Trojan L, Uhlig J, Leitsmann C (2018) Primary bladder adenocarcinoma: Case report with long-term follow-up. Urol Case Rep 18: 64-66, doi: 10.1016/j.eucr.2018.02.006
  16. Uhlig A, Hahn O, Strauss A, Lotz J, Trojan L, Müller-Wille R, Uhlig J (2018) Treatment for Localized T1a Clear Cell Renal Cell Carcinoma: Survival Benefit for Cryosurgery and Thermal Ablation Compared to Deferred Therapy. CARDIOVASC INTER RAD 41(2): 277-283, doi: 10.1007/s00270-017-1816-9
  17. Uhlig A, Mei J, Baik I, Meyer C, Uhlig J (2018) Screening utilization among cancer survivors: a meta-analysis. J Public Health (Oxf) 40(1): 129-137, doi: 10.1093/pubmed/fdx030
  18. Uhlig A, Seif Amir Hosseini A, Simon J, Lotz J, Trojan L, Schmid M, Uhlig J (2018) Gender Specific Differences in Disease-Free, Cancer Specific and Overall Survival after Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis. J UROLOGY 200(1): 48-60, doi: 10.1016/j.juro.2017.11.150
  19. Uhlig J, Uhlig A, Kunze M, Beissbarth T, Fischer U, Lotz J, Wienbeck S (2018) Novel Breast Imaging and Machine Learning: Predicting Breast Lesion Malignancy at Cone-Beam CT Using Machine Learning Techniques. AM J ROENTGENOL 211(2): W123-W131, doi: 10.2214/AJR.17.19298
  20. Vetterlein MW, Gild P, Kluth LA, Seisen T, Gierth M, Fritsche HM, Burger M, Protzel C, Hakenberg OW, von Landenberg N, Roghmann F, Noldus J, Nuhn P, Pycha A, Rink M, Chun FKH, May M, Fisch M, Aziz A, PROMETRICS 2011 Study Group (2018) Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study. BJU INT 121(1): 101-110, doi: 10.1111/bju.14012

Publikationen 2017

  1. Dulz S, Asselborn NH, Dieckmann KP, Matthies C, Wagner W, Weidmann J, Seidel C, Oing C, Berger LA, Alsdorf W, Mankichian B, Meyer C, Vetterlein MW, Gild P, Ludwig TA, Soave A, Schriefer P, Becker A, Ahyai SA, Oechsle K, Bokemeyer C, Wagenfeld L, Fisch M, Hartmann M, Chun FKH, Kluth LA (2017) Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancer. J CANCER RES CLIN 143(7): 1319-1325, doi: 10.1007/s00432-017-2384-8
  2. Gehrig J, Kaulfuß S, Jarry H, Bremmer F, Stettner M, Burfeind P, Thelen P (2017) Prospects of estrogen receptor β activation in the treatment of castration-resistant prostate cancer. ONCOTARGET 8(21): 34971-34979, doi: 10.18632/oncotarget.16496
  3. Hijazi S, Echtle D, Aboumarzouk OM, Heinrich E (2017) Abdominal sacrocolpopexy with Pelvicol xenograft and concomitant Burch colposuspension. Int J Womens Health 9: 625-630, doi: 10.2147/IJWH.S134239
  4. Kesch C, Radtke JP, Popeneciu IV, Gasch C, Dieffenbacher SC, Klein T, Schlemmer HP, Wieczorek K, Zogal P, Hohenfellner M, Sakas G, Hadaschik BA (2017) TOP: Prospective Evaluation of a Volume Based, Computer Assisted Method for Transperineal Optimized Prostate Biopsy. UROL INT 99(2): 149-155, doi: 10.1159/000458764
  5. Martinschek A, Stumm L, Ritter M, Heinrich E, Bolenz C, Trojan L (2017) Prospective, Controlled Study of Invasiveness and Post-Aggression Metabolism in Patients Undergoing Robotic-Assisted Radical Prostatectomy. UROL INT 99(2): 201-206, doi: 10.1159/000478027
  6. Naspro R, Gomez Sancha F, Manica M, Meneghini A, Ahyai S, Aho T, Fiori C, Vavassori I, DA Pozzo LF, Pansadoro V, Montorsi F, Herrmann TR (2017) From "gold standard" resection to reproducible "future standard" endoscopic enucleation of the prostate: what we know about anatomical enucleation. MINERVA UROL NEFROL 69(5): 446-458, doi: 10.23736/S0393-2249.17.02834-X
  7. Ohlmann CH, Thelen P (2017) [Antihormonal therapy in prostate cancer : Side effects]. UROLOGE 56(4): 465-471, doi: 10.1007/s00120-017-0340-5
  8. Rosenbaum CM, Reiss CP, Borgmann H, Salem J, Fisch M, Huber J, Schmid M, Ahyai SA (2017) Management of Anterior Urethral Strictures in Adults: A Survey of Contemporary Practice in Germany. UROL INT 99(1): 43-50, doi: 10.1159/000471928
  9. Salem J, Borgmann H, Baunacke M, Boehm K, Hanske J, Macneily A, Meyer C, Nestler T, Schmid M, Huber J (2017) Widespread use of internet, applications, and social media in the professional life of urology residents. CUAJ-CAN UROL ASSOC 11(9): E355-E366, doi: 10.5489/cuaj.4267
  10. Soave A, Dahlem R, Pinnschmidt HO, Rink M, Langetepe J, Engel O, Kluth LA, Loechelt B, Reiss P, Ahyai SA, Fisch M (2017) Substitution Urethroplasty with Closure Versus Nonclosure of the Buccal Mucosa Graft Harvest Site: A Randomized Controlled Trial with a Detailed Analysis of Oral Pain and Morbidity. EUR UROL -: -, doi: 10.1016/j.eururo.2017.11.014
  11. Taubert H, Becker C, Füssel S, Seitz G, Thelen P, Wullich B (2017) [The 14th annual DPKK meeting on "Importance of molecular analysis for diagnosis and therapy"]. UROLOGE 56(6): 808-810, doi: 10.1007/s00120-017-0404-6
  12. Traceviciute J, Zwink N, Jenetzky E, Reutter H, Hirsch K, Stein R, Rösch WH, Ebert AK (2017) Sexual Function and Quality of Life in Adult Male Individuals with Exstrophy-Epispadias Complex-a Survey of the German CURE-Network. UROLOGY -: -, doi: 10.1016/j.urology.2017.08.063
  13. Tsaur I, Becker C, Thelen P, Roos FC (2017) [Splice variant AR-V7 : Is it time for its routine use as a predictive marker in prostate cancer?]. UROLOGE 56(9): 1164-1167, doi: 10.1007/s00120-017-0461-x
  14. Uhlig A, Borkowetz A (2017) [Possibilities of rehabilitation programmes for adult cancer survivors]. UROLOGE 56(12): 1611-1614, doi: 10.1007/s00120-017-0537-7
  15. Uhlig A, Mei J, Baik I, Meyer C, Uhlig J (2017) Screening utilization among cancer survivors: a meta-analysis. J Public Health (Oxf) -: 1-9, doi: 10.1093/pubmed/fdx030
  16. Uhlig A, Strauss A, Seif Amir Hosseini A, Lotz J, Trojan L, Schmid M, Uhlig J (2017) Gender-specific Differences in Recurrence of Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. Eur Urol Focus -: -, doi: 10.1016/j.euf.2017.08.007
  17. von Hardenberg J, Schwartz M, Werner T, Fuxius S, Strauss A, Worst TS, Nuhn P, Bolenz C, Heinrich E (2017) Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review. UROL INT 99(4): 414-421, doi: 10.1159/000477943
  18. von Hardenberg J, Schwartz M, Werner T, Fuxius S, Müller M, Frangenheim T, Bolenz C, Weiss C, Heinrich E (2017) Prospective Evaluation of Neuromediator Dynamics in Castration-Resistant Prostate Cancer Patients During Docetaxel. ANTICANCER RES 37(9): 5117-5124, doi: 10.21873/anticanres.11931

Publikationen 2016

  1. Ahyai SA, Ludwig TA, Dahlem R, Soave A, Rosenbaum C, Chun FKH, Fisch M, Schmid M, Kluth LA (2016) Outcomes of single- vs double-cuff artificial urinary sphincter insertion in low- and high-risk profile male patients with severe stress urinary incontinence. BJU INT 118(4): 625-32, doi: 10.1111/bju.13449
  2. Hijazi S, Leitsmann C (2016) Clinical significance of video-urodynamic in female recurrent urinary tract infections. Int J Womens Health 8: 31-4, doi: 10.2147/IJWH.S94956
  3. Hijazi S, Echtle D, Hasselhof VM, Trojan L, Heinrich E (2016) Metal telescopic and Amplatz sheath dilation in nephrolithotomy. Urol Ann 8(1): 66-9, doi: 10.4103/0974-7796.163795
  4. Hijazi S, Meller B, Leitsmann C, Strauss A, Ritter C, Lotz J, Meller J, Trojan L, Sahlmann CO (2016) See the unseen: Mesorectal lymph node metastases in prostate cancer. PROSTATE 76(8): 776-80, doi: 10.1002/pros.23168
  5. Martini T, Aziz A, Roghmann F, Rink M, Chun FK, Fisch M, Trojan L, Hakenberg OW, Zastrow S, Wirth MP, Moersdorf J, Brookman-May S, Stief CG, Haferkamp A, Wagenlehner F, Hohenfellner M, Herrmann E, Lusuardi L, Grimm MO, Müller SC, Roigas J, Bastian PJ, Gierth M, Burger M, Pycha A, Seitz C, May M, Bolenz C (2016) Prediction of Locally Advanced Urothelial Carcinoma of the Bladder Using Clinical Parameters before Radical Cystectomy - A Prospective Multicenter Study. UROL INT 96(1): 57-64, doi: 10.1159/000433606
  6. Martinschek A, Pfalzgraf D, Rafail B, Ritter M, Heinrich E, Trojan L (2016) Transurethral versus suprapubic catheter at robot-assisted radical prostatectomy: a prospective randomized trial with 1-year follow-up. WORLD J UROL 34(3): 407-11, doi: 10.1007/s00345-015-1678-1
  7. Paffenholz P, Borgmann H, Nachite-Berges S, Borowitz R, Bründl J, Boehm K, Probst K, Schneidewind L, Schmid M, Salem J (2016) [Regional for Residents. GeSRU Programs at Regional Urology Meetings in Germany]. UROLOGE 55(4): 532-3, doi: 10.1007/s00120-016-0053-1
  8. Rosenbaum CM, Schmid M, Ludwig TA, Kluth LA, Dahlem R, Fisch M, Ahyai S (2016) Redo buccal mucosa graft urethroplasty: success rate, oral morbidity and functional outcomes. BJU INT 118(5): 797-803, doi: 10.1111/bju.13528
  9. Sahlmann CO, Meller B, Bouter C, Ritter CO, Ströbel P, Lotz J, Trojan L, Meller J, Hijazi S (2016) Biphasic ⁶⁸Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma. EUR J NUCL MED MOL I 43(5): 898-905, doi: 10.1007/s00259-015-3251-y
  10. Salem J, Borgmann H, MacNeily A, Boehm K, Schmid M, Groeben C, Baunacke M, Huber J (2016) New Media for Educating Urology Residents: An Interview Study in Canada and Germany. J Surg Educ epub: S1931-7204(16)30321-X, doi: 10.1016/j.jsurg.2016.11.009
  11. Taubert H, Becker C, Füssel S, Seitz G, Thelen P, Wullich B (2016) [Annual meeting of the German Prostate Cancer Consortium: Updates to circulating tumor cells, "liquid biopsy" and the role of the androgen receptor]. UROLOGE 55(5): 661-2, doi: 10.1007/s00120-016-0105-6
  12. Thelen P, Gschwend J, Wolff JM, Miller K (2016) [Mechanisms of Resistance in Antihormone Therapies of Advanced Prostate Cancer]. AKTUEL UROL 47(1): 79-85, doi: 10.1055/s-0041-108295
  13. Waegner RH, Schmid M, Trojan L, Ahyai SA (2016) [Retroperitoneal endometriosis : When a rare form of endometriosis becomes a urological disease]. UROLOGE 55(6): 756-62, doi: 10.1007/s00120-016-0119-0

Publikationen 2015

  1. Bremmer F, Schallenberg S, Jarry H, Küffer S, Kaulfuss S, Burfeind P, Strauß A, Thelen P, Radzun HJ, Ströbel P, Honecker F, Behnes CL (2015) Role of N-cadherin in proliferation, migration, and invasion of germ cell tumours. ONCOTARGET 6(32): 33426-37, doi: 10.18632/oncotarget.5288
  2. Hijazi S, Meller B, Leitsmann C, Strauss A, Meller J, Ritter CO, Lotz J, Schildhaus HU, Trojan L, Sahlmann CO (2015) Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by 68Ga-PSMA-positron emission tomography/computerized tomography. PROSTATE 75(16): 1934-40, doi: 10.1002/pros.23091
  3. Klümper N, Syring I, Offermann A, Shaikhibrahim Z, Vogel W, Müller SC, Ellinger J, Strauß A, Radzun HJ, Ströbel P, Brägelmann J, Perner S, Bremmer F (2015) Differential expression of Mediator complex subunit MED15 in testicular germ cell tumors. DIAGN PATHOL 10: 165, doi: 10.1186/s13000-015-0398-6
  4. Kübler H, Scheel B, Gnad-Vogt U, Miller K, Schultze-Seemann W, Vom Dorp F, Parmiani G, Hampel C, Wedel S, Trojan L, Jocham D, Maurer T, Rippin G, Fotin-Mleczek M, von der Mülbe F, Probst J, Hoerr I, Kallen KJ, Lander T, Stenzl A (2015) Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study. J Immunother Cancer 3: 26, doi: 10.1186/s40425-015-0068-y
  5. Meller B, Bremmer F, Sahlmann CO, Hijazi S, Bouter C, Trojan L, Meller J, Thelen P (2015) Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy. EJNMMI Res 5(1): 66, doi: 10.1186/s13550-015-0145-8

Publikationen 2014

  1. Behnes CL, Bremmer F, Hemmerlein B, Strauss A, Ströbel P, Radzun HJ (2014) Tumor-associated macrophages are involved in tumor progression in papillary renal cell carcinoma. VIRCHOWS ARCH 464(2): 191-6, doi: 10.1007/s00428-013-1523-0
  2. Böttner M, Thelen P, Jarry H (2014) Estrogen receptor beta: tissue distribution and the still largely enigmatic physiological function. J STEROID BIOCHEM 139: 245-51, doi: 10.1016/j.jsbmb.2013.03.003
  3. Bremmer F, Jarry H, Strauß A, Behnes CL, Trojan L, Thelen P (2014) Increased expression of CYP17A1 indicates an effective targeting of the androgen receptor axis in castration resistant prostate cancer (CRPC). Springerplus 3: 574, doi: 10.1186/2193-1801-3-574
  4. Gierth M, Fritsche HM, Buchner H, May M, Aziz A, Otto W, Bolenz C, Trojan L, Hermann E, Tiemann A, Müller SC, Ellinger J, Brookman-May S, Stief CG, Tilki D, Nuhn P, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Wieland WF, Riedmiller H, Denzinger S, Bastian PJ, Burger M (2014) Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation. WORLD J UROL 32(2): 365-71, doi: 10.1007/s00345-013-1105-4
  5. Harke N, Schoen G, Schiefelbein F, Heinrich E (2014) Selective clamping under the usage of near-infrared fluorescence imaging with indocyanine green in robot-assisted partial nephrectomy: a single-surgeon matched-pair study. WORLD J UROL 32(5): 1259-65, doi: 10.1007/s00345-013-1202-4
  6. Thelen P, Wuttke W, Seidlová-Wuttke D (2014) Phytoestrogens selective for the estrogen receptor beta exert anti-androgenic effects in castration resistant prostate cancer. J STEROID BIOCHEM 139: 290-3, doi: 10.1016/j.jsbmb.2013.06.009

Publikationen 2013

  1. Becker F, Junker K, Parr M, Hartmann A, Füssel S, Toma M, Grobholz R, Pflugmann T, Wullich B, Strauss A, Behnes CL, Otto W, Stöckle M, Jung V (2013) Collecting duct carcinomas represent a unique tumor entity based on genetic alterations. PLOS ONE, 8(10): e78137.
  2. Behnes CL, Bedke J, Schneider S, Küffer S, Strauss A, Bremmer F, Ströbel P, Radzun HJ (2013) Myoglobin expression in renal cell carcinoma is regulated by hypoxia. EXP MOL PATHOL, 95(3): 307-12.
  3. Behnes CL, Schlegel C, Shoukier M, Magiera I, Henschke F, Schwarz A, Bremmer F, Loertzer H (2013) Hereditary papillary renal cell carcinoma primarily diagnosed in a cervical lymph node: a case report of a 30-year-old woman with multiple metastases. BMC UROL, 13: 3.
  4. Bolenz C, Auer M, Ströbel P, Heinzelbecker J, Schubert C, Trojan L (2013) The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value. UROL ONCOL-SEMIN ORI, 31(8): 1606-14.
  5. Buchner A, May M, Burger M, Bolenz C, Herrmann E, Fritsche HM, Ellinger J, Höfner T, Nuhn P, Gratzke C, Brookman-May S, Melchior S, Peter J, Moritz R, Tilki D, Gilfrich C, Roigas J, Zacharias M, Hohenfellner M, Haferkamp A, Trojan L, Wieland WF, Müller SC, Stief CG, Bastian PJ (2013) Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks. EJSO-EUR J SURG ONC, 39(4): 372-9.
  6. Hasibeder A, Venkataramani V, Thelen P, Radzun HJ, Schweyer S (2013) Phytoestrogens regulate the proliferation and expression of stem cell factors in cell lines of malignant testicular germ cell tumors. INT JONCOL, 43(5): 1385-94.
  7. Heidenreich A, Scholz HJ, Rogenhofer S, Arsov C, Retz M, Müller SC, Albers P, Gschwend J, Wirth M, Steiner U, Miller K, Heinrich E, Trojan L, Volkmer B, Honecker F, Bokemeyer C, Keck B, Otremba B, Ecstein-Fraisse E, Pfister D (2013) Cabazitaxel plus prednisone for metastatic castration-resistant prostate cancer progressing after docetaxel: results from the German compassionate-use programme. EUR UROL, 63(6): 977-82.
  8. Heinzelbecker J, Katzmarzik M, Weiss C, Trojan L, Haecker A (2013) During twenty years of Cisplatinbased therapy the face of nonseminomatous testicular germ cell tumors is still changing: an evaluation of presentation, management, predictive factors and survival. Int Braz J Urol, 39(1): 10-21.
  9. Heinzelbecker J, Kempf KM, Kurz K, Steidler A, Weiss C, Jackson DG, Bolenz C, Haecker A, Trojan L (2013) Lymph vessel density in seminomatous testicular cancer assessed with the specific lymphatic endothelium cell markers D2-40 and LYVE-1: correlation with pathologic parameters and clinical outcome. UROL ONCOL-SEMIN ORI, 31(7): 1386-94.
  10. Loertzer H, Schneider P (2013) [Stress incontinence in elderly women]. UROLOGE, 52(6): 813-20.
  11. Loertzer H, Strauß A, Ringert RH, Schneider P (2013) Laser-supported partial laparoscopic nephrectomy for renal cell carcinoma without ischaemia time. BMC UROL, 13: 31.
  12. Lumma PP, Schneider P, Strauss A, Plothe KD, Thelen P, Ringert RH, Loertzer H (2013) Impact of ureteral stenting prior to ureterorenoscopy on stone-free rates and complications. WORLD J UROL, 31(4): 855-9.
  13. May M, Bastian PJ, Brookman-May S, Fritsche HM, Tilki D, Otto W, Bolenz C, Gilfrich C, Trojan L, Herrmann E, Moritz R, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Wieland WF, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M (2013) Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a. UROL ONCOL-SEMIN ORI, 31(7): 1141-7.
  14. Thelen P, Heinrich E, Bremmer F, Trojan L, Strauss A (2013) Testosterone boosts for treatment of castration resistant prostate cancer: an experimental implementation of intermittent androgen deprivation. PROSTATE, 73(15): 1699-709.
  15. Thelen P, Krahn L, Bremmer F, Strauss A, Brehm R, Loertzer H (2013) Synergistic effects of histone deacetylase inhibitor in combination with mTOR inhibitor in the treatment of prostate carcinoma. INT J MOL MED, 31(2): 339-46.
  16. Witt D, Burfeind P, von Hardenberg S, Opitz L, Salinas-Riester G, Bremmer F, Schweyer S, Thelen P, Neesen J, Kaulfuss S (2013) Valproic acid inhibits the proliferation of cancer cells by re-expressing cyclin D2. CARCINOGENESIS, 34(5): 1115-24.

Publikationen 2012

  1. Behnes CL, Hemmerlein B, Strauss A, Radzun HJ, Bremmer F (2012) N-cadherin is differentially expressed in histological subtypes of papillary renal cell carcinoma. DIAGN PATHOL, 7: 95.
  2. Bolenz C, Auer M, Ströbel P, Heinzelbecker J, Schubert C, Trojan L (2012) The lymphatic system in clinically localized urothelial carcinoma of the bladder: Morphologic characteristics and predictive value. UROL ONCOL-SEMIN ORI, x: x.
  3. Bremmer F, Thelen P, Pottek T, Behnes CL, Radzun HJ, Schweyer S (2012) Expression and function of the vitamin D receptor in malignant germ cell tumour of the testis. ANTICANCER RES, 32(1): 341-9.
  4. Bremmer F, Hemmerlein B, Strauss A, Burfeind P, Thelen P, Radzun HJ, Behnes CL (2012) N-cadherin expression in malignant germ cell tumours of the testis. BMC Clin Pathol, 12(1): 19.
  5. Bremmer F, Kessel FJ, Behnes CL, Trojan L, Heinrich E (2012) Leiomyoma of the tunica albuginea, a case report of a rare tumour of the testis and review of the literature. DIAGN PATHOL, 7: 140.
  6. Gabriel U, Li L, Bolenz C, Steidler A, Kränzlin B, Saile M, Gretz N, Trojan L, Michel MS (2012) New insights into the influence of cigarette smoking on urothelial carcinogenesis: smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer. MOL CARCINOGEN, 51(11): 907-15.
  7. Heinzelbecker J, Gropp T, Weiss C, Huettl K, Stroebel P, Haecker A, Bolenz C, Trojan L (2012) The role of lymph vessel density and lymphangiogenesis in metastatic tumor spread of nonseminomatous testicular germ cell tumors. UROL ONCOL-SEMIN ORI, 11: 1078-1439.
  8. Herrmann MKA, Kertesz T, Gsänger T, Bloch E, Pollul G, Bouabdallaoui M, Strauss A, Herrmann M, Christiansen H, Wolff HA, Hess CF, Hille A (2012) Gold marker displacement due to needle insertion during HDR-brachytherapy for treatment of prostate cancer: a prospective cone beam computed tomography and kilovoltage on-board imaging (kV-OBI) study. RADIAT ONCOL, 7: 24.
  9. Loertzer H, Schneider P, Thelen P, Ringert RH, Strauß A (2012) [Laser now also to be used in organ-preserving kidney surgery?]. UROLOGE, 51(6): 837-42.
  10. Loertzer H, Schneider P, Thelen P, Ringert RH, Strauß A (2012) [Prolapse surgery. With abdominal or vaginal meshes?]. UROLOGE, 51(9): 1261-9.
  11. Martinschek A, Heinzelmann K, Ritter M, Heinrich E, Trojan L (2012) Radical prostatectomy after previous transurethral resection of the prostate: robot-assisted laparoscopic versus open radical prostatectomy in a matched-pair analysis. J ENDOUROL, 26(9): 1136-41.
  12. May M, Bastian PJ, Brookman-May S, Fritsche HM, Bolenz C, Gilfrich C, Otto W, Trojan L, Herrmann E, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M (2012) External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladder. J UROLOGY, 187(4): 1210-4.
  13. Nuhn P, May M, Fritsche HM, Buchner A, Brookman-May S, Bolenz C, Moritz R, Herrmann E, Burger M, Höfner T, Ellinger J, Tilki D, Roigas J, Zacharias M, Trojan L, Wülfing C, May F, Melchior S, Haferkamp A, Gilfrich C, Hohenfellner M, Wieland WF, Müller SC, Stief CG, Bastian PJ (2012) External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder. EJSO-EUR J SURG ONC, 38(7): 637-42.
  14. Nuhn P, May M, Sun M, Fritsche HM, Brookman-May S, Buchner A, Bolenz C, Moritz R, Herrmann E, Burger M, Tilki D, Trojan L, Perrotte P, Haferkamp A, Hohenfellner M, Wieland WF, Müller SC, Karakiewicz PI, Bastian PJ (2012) External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder. EUR UROL, 61(1): 58-64.
  15. Ohlmann CH, Merseburger AS, Suttmann H, Schilling D, Trojan L, Kempkensteffen C, Corvin S, Mathers MJ, Bastian PJ (2012) Novel options for the treatment of castration-resistant prostate cancer. WORLD J UROL, 30(4): 495-503.
  16. Otto W, May M, Fritsche HM, Dragun D, Aziz A, Gierth M, Trojan L, Herrmann E, Moritz R, Ellinger J, Tilki D, Buchner A, Höfner T, Brookman-May S, Nuhn P, Gilfrich C, Roigas J, Zacharias M, Denzinger S, Hohenfellner M, Haferkamp A, Müller SC, Kocot A, Riedmiller H, Wieland WF, Stief CG, Bastian PJ, Burger M (2012) Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder. GENDER MED, 9(6): 481-9.
  17. Prado LG, Huber J, Huber CG, Mogler C, Ehrenheim J, Nyarangi-Dix J, Pahernik S, Hohenfellner M (2012) Penile methadone injection in suicidal intent: life-threatening and fatal for erectile function. J ANDROL, 33(5): 801-4.
  18. Schaefer IM, Seeliger S, Strauss A, Füzesi L, Ringert RH, Loertzer H (2012) A three-step technique for umbilicoplasty in a patent urachus. BJU INT, 109(4): 640-4.
  19. Schmitz-Dräger BJ, Lümmen G, Bismarck E, Fischer C, Mitglieder des Arbeitskreises Prävention Umwelt und Komplementärmedizin (PUK) der Deutschen Gesellschaft für Urologie e. V. (DGU) (2012) [Prevention of uro-oncological diseases]. UROLOGE, 51(5): 727-36.
  20. Stettner M, Krämer G, Strauss A, Kvitkina T, Ohle S, Kieseier BC, Thelen P (2012) Long-term antiepileptic treatment with histone deacetylase inhibitors may reduce the risk of prostate cancer. EUR J CANCER PREV, 21(1): 55-64.
  21. Thelen P, Ringert RH, Loertzer H, Strauß A (2012) [Intermittent androgen deprivation as therapy for androgen-sensitive prostate cancer. Sense or nonsense?]. UROLOGE, 51(9): 1240-5.
  22. Tunn UW, Stenzl A, Schultze-Seemann W, Strauss A, Kindler M, Miller K, Wirth MP, Zantl N, Schulze M, May C, Ruebel A, Birkholz K, Gruenwald V (2012) Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases. CAN J UROL, 19(3): 6261-7.
  23. Venkataramani V, Thiele K, Behnes CL, Wulf GG, Thelen P, Opitz L, Salinas-Riester G, Wirths O, Bayer TA, Schweyer S (2012) Amyloid precursor protein is a biomarker for transformed human pluripotent stem cells. AM J PATHOL, 180(4): 1636-52.

Das könnte Sie auch interessieren

Folgen Sie uns